New Product: Isturisa (osilodrostat phosphate) film coated tablets – all strengths
Osilodrostat phosphate is licensed for the treatment of endogenous Cushing's syndrome in adults; and should be initiated and supervised by physicians experienced in endocrinology with access to facilities for monitoring of cortisol levels.
Source:
electronic Medicines compendium